Daytime Hypersomnolence in Migraine : Prevalence , Clinical Correlates and Independent Predictors in Malaysia
Abstract
Abstract Background and objectives Sleep disturbances, including daytime hypersomnolence, are increasingly recognized as clinically significant comorbidities of migraine that adversely affect quality of life. However, data on the prevalence and determinants of daytime hypersomnolence among migraine patients in Malaysia and the broader Southeast Asian region remain limited. This study aimed to determine the prevalence of daytime hypersomnolence and to identify the clinical and sociodemographic factors associated with excessive daytime sleepiness in adult patients with migraine. Methods A single-center, cross-sectional study was conducted between April 2024 and April 2026 at the Neurology Clinic, Hospital Canselor Tuanku Muhriz (HCTM), Universiti Kebangsaan Malaysia (UKM). Eligible participants were adults aged 18 years and above with an established diagnosis of migraine for at least one year, confirmed by a neurologist according to the International Classification of Headache Disorders, Third Edition (ICHD-3) criteria. Baseline sociodemographic and clinical migraine data were systematically collected. Daytime hypersomnolence was assessed using the validated Epworth Sleepiness Scale (ESS), with a score exceeding 10 defining the outcome. Migraine-related disability was assessed using the Migraine Disability Assessment (MIDAS) questionnaire. Data were analyzed using IBM SPSS Statistics Version 29, with binary logistic regression performed to identify independent predictors.…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 278 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.